Dear Colleague,

The Genome-wide Partnering & Deal-making Conference is a partnering and business development conference for pharmaceutical, diagnostics, technology and healthcare companies. The conference will discuss investments and partnerships in the genomic field, companion diagnostics and partnering for personalized medicine, regulatory and reimbursement issues and the ethical, legal and social implications (ELSI) of human genome sequencing.

The following are the sessions for the conference:

 

Genome-wide Partnering & Deal-making

Partnering for Personalized Medicine

Technologies in Genomic and Diagnostic Partnering

Companion Diagnostic Partnering Business Models

Regulatory and Reimbursement Issues and Trends

Genome-wide ELSI (Ethical, Legal and Social Issues)

Panel Discussion: The Future of Pharma-Diagnostic Partnering

Genome-wide Industry and Academia Collaboration

 

The Genome-wide Partnering & Deal-making Conference is part of the Omics Evolution Summit, which includes 6 co-located conferences and an optional Clinical Sequencing Workshop on May 29th. Register for the entire summit and have access to the all of the following conferences:


2^nd Genomic & Proteomic Drug Discovery Conference
2^nd Next Generation Sequencing Conference
2nd Epigenetics in Drug Discovery Conference
3rd RNAi Research and Development Conference
7^th Protein Kinases in Drug Discovery Conference

We look forward to seeing you at the conference!